Stacking Protection. If Licensee becomes obligated to pay royalties to third parties for technology necessary to develop or manufacture a Licensed Product, then the royalty rate payable to Rockefeller under Section 2.4 for such Licensed Product will be reduced pro rata with respect to all third party royalty rates, so as to reduce the maximum aggregate royalty rate to [***]percent ([***]%). A reduction of the royalty rate in Section 2.4 for one Licensed Product will not affect the royalty rate for another Licensed Product.
Appears in 2 contracts
Sources: License Agreement (Rosetta Genomics Ltd.), License Agreement (Rosetta Genomics Ltd.)